相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Implementation of a standardized multimodal pain regimen significantly reduces postoperative inpatient opioid utilization in patients undergoing bariatric surgery
Wen Hui Tan et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2023)
Lamotrigine therapy in patients after bariatric surgery: Potentially hampered solubility and dissolution
Daniel Porat et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Radiographic Measurement of Gastric Remnant Volume After Laparoscopic Sleeve Gastrectomy: Assessment of Reproducibility and Correlation with Weight Loss
Malgorzata Deregowska-Cylke et al.
OBESITY SURGERY (2022)
Implications of Bariatric Surgery on the Pharmacokinetics of Antiretrovirals in People Living with HIV
Leena Zino et al.
CLINICAL PHARMACOKINETICS (2022)
Changes in Gastric Inhibitory Polypeptide (GIP) After Roux-en-Y Gastric Bypass in Obese Patients: a Meta-analysis
Zhiguang Gao et al.
OBESITY SURGERY (2022)
Prediction Factors of Early Postoperative Bleeding after Bariatric Surgery
Mahdieh Golzarand et al.
OBESITY SURGERY (2022)
Nonsteroid anti-inflammatory drugs and the risk of peptic ulcers after gastric bypass and sleeve gastrectomy
Martin L. Skogar et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2022)
Antiallergic Treatment of Bariatric Patients: Potentially Hampered Solubility/Dissolution and Bioavailability of Loratadine, but Not Desloratadine, Post-Bariatric Surgery
Daniel Porat et al.
MOLECULAR PHARMACEUTICS (2022)
Influence of Bariatric Surgery on Levetiracetam Clinical Effectiveness: Case Series
Nadia Margolin et al.
OBESITY SURGERY (2022)
Carbamazepine Therapy After Bariatric Surgery: Eight Sleeve Gastrectomy Cases and Review of the Literature
Daniel Porat et al.
OBESITY SURGERY (2022)
A Simple One-Parameter Percent Dissolved Versus Time Dissolution Equation that Accommodates Sink and Non-sink Conditions via Drug Solubility and Dissolution Volume
James E. Polli
AAPS JOURNAL (2022)
Drug absorption in bariatric surgery patients: A narrative review
Abdullah Abdulaziz Alalwan et al.
HEALTH SCIENCE REPORTS (2022)
Short- and long-term effects of body weight loss following calorie restriction and gastric bypass on CYP3A-activity - a non-randomized three-armed controlled trial
Kine Eide Kvitne et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)
Nonsteroid anti-inflammatory drugs and the risk of peptic ulcers after gastric bypass and sleeve gastrectomy
Martin L. Skogar et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2022)
Rheumatoid Arthritis Pathogenesis, Prediction, and Prevention: An Emerging Paradigm Shift
Kevin D. Deane et al.
ARTHRITIS & RHEUMATOLOGY (2021)
The effect of weight reduction surgery on the efficacy and tolerability of epilepsy pharmacotherapy
James D. Triplett et al.
EPILEPSY & BEHAVIOR (2021)
Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial
Geltrude Mingrone et al.
LANCET (2021)
Stomach pH before vs. after different bariatric surgery procedures: Clinical implications for drug delivery
Daniel Porat et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
Can NSAIDs and Acetaminophen Effectively Replace Opioid Treatment Options for Acute Pain?
Joseph Pergolizzi et al.
EXPERT OPINION ON PHARMACOTHERAPY (2021)
Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis
Bai-Ru Cheng et al.
PLOS ONE (2021)
The use of nonsteroidal anti-inflammatory drugs after sleeve gastrectomy
Alan Begian et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2021)
Adaptations in gastrointestinal physiology after sleeve gastrectomy and Roux-en-Y gastric bypass
Nele Steenackers et al.
Lancet Gastroenterology & Hepatology (2021)
Oral drug dosing following bariatric surgery: General concepts and specific dosing advice
Jurjen S. Kingma et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Managing the Unpredictable: Mechanistic Analysis and Clinical Recommendations for Lamotrigine Treatment after Bariatric Surgery
Daniel Porat et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Optimized In Silico Modeling of Drug Absorption after Gastric Bypass: The Case of Metformin
Arik Dahan et al.
PHARMACEUTICS (2021)
The Effects of Bariatric Surgery and Gastrectomy on the Absorption of Drugs, Vitamins, and Mineral Elements
Milosz Miedziaszczyk et al.
PHARMACEUTICS (2021)
Evaluating the Impact of Physiological Properties of the Gastrointestinal Tract On Drug In Vivo Performance Using Physiologically Based Biopharmaceutics Modeling and Virtual Clinical Trials
Rebeka Jereb et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Long-Term Efficacy of Bariatric Surgery for the Treatment of Super-Obesity: Comparison of SG, RYGB, and OAGB
Tien-Chou Soong et al.
OBESITY SURGERY (2021)
Managing postoperative pain in adult outpatients: a systematic review and meta-analysis comparing codeine with NSAIDs
Matthew Choi et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)
Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis
Niloufar Salehi et al.
MOLECULAR PHARMACEUTICS (2021)
Case Report of Increased Exposure to Antiretrovirals following Sleeve Gastrectomy
Sarah Israel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Obesity and its role in the management of rheumatoid and psoriatic arthritis
Luca Moroni et al.
CLINICAL RHEUMATOLOGY (2020)
Medication Management after Bariatric Surgery: Providing Optimal Patient Care
Daniel Porat et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Combined Laparoscopic Revision of the Gastric Pouch and Distalization of the Roux Limb After Failure of Weight Loss Following Roux-en-Y Gastric Bypass
Tarek Debs et al.
OBESITY SURGERY (2020)
Effect of thickener on disintegration, dissolution and permeability of common drug products for elderly patients
Alejandro Ruiz-Picazo et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Lithium toxicity with prolonged neurologic sequelae following sleeve gastrectomy A case report and review of literature
Yi-Hsin Lin et al.
MEDICINE (2020)
Physiologically Based Pharmacokinetic Modeling of Transdermal Selegiline and Its Metabolites for the Evaluation of Disposition Differences between Healthy and Special Populations
Santosh Kumar Puttrevu et al.
PHARMACEUTICS (2020)
Association between Overweight/Obesity and Clinical Activity in Rheumatoid Arthritis
Jose Alvarez-Nemegyei et al.
REUMATOLOGIA CLINICA (2020)
Assessment of the Correlation Between Preoperative and Immediate Postoperative Gastric Volume and Weight Loss After Sleeve Gastrectomy Using Computed Tomography Volumetry
Hosam Elbanna et al.
WORLD JOURNAL OF SURGERY (2019)
Celecoxib for the treatment of musculoskeletal arthritis
Marco Krasselt et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review
Philip Carlo Angeles et al.
OBESITY REVIEWS (2019)
Ketorolac Use Shortens Hospital Length of Stay After Bariatric Surgery: a Single-Center 5-Year Experience
Kamyar Hariri et al.
OBESITY SURGERY (2019)
Increased Paracetamol Bioavailability after Sleeve Gastrectomy: A Crossover Pre- vs. Post-Operative Clinical Trial
Daniel Porat et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Perioperative Opioid-sparing Strategies: Utility of Conventional NSAIDs in Adults
Luc Martinez et al.
CLINICAL THERAPEUTICS (2019)
Lithium Toxicity with Severe Bradycardia Post Sleeve Gastrectomy: a Case Report and Review of the Literature
Arik Dahan et al.
OBESITY SURGERY (2019)
Multimodal Postoperative Pain Control Is Effective and Reduces Opioid Use After Laparoscopic Roux-en-Y Gastric Bypass
Ryan D. Horsley et al.
OBESITY SURGERY (2019)
Safety and Efficacy of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Used for Analgesia After Bariatric Surgery: A Retrospective Case-Control Study
Hicham Abou Zeid et al.
OBESITY SURGERY (2019)
Oral levothyroxine therapy postbariatric surgery: Biopharmaceutical aspects and clinical effects
Carmil Azran et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2019)
Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity
Jose Rodriguez-Morato et al.
SCIENTIFIC REPORTS (2019)
Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective
Mohamad Shebley et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
The Combination of GIS and Biphasic to Better Predict In Vivo Dissolution of BCS Class IIb Drugs, Ketoconazole and Raloxifene
Yasuhiro Tsume et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Obesity Management Task Force of the European Association for the Study of Obesity Released Practical Recommendations for the Post-Bariatric Surgery Medical Management
Luca Busetto et al.
OBESITY SURGERY (2018)
Stability Study of Etoricoxib a Selective Cyclooxygenase-2 Inhibitor by a New Single and Rapid Reversed Phase HPLC Method
Muhammad Alzweiri et al.
SYMMETRY-BASEL (2018)
Reverse Translation in PBPK and QSP: Going Backwards in Order to Go Forward With Confidence
Amin Rostami-Hodjegan
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Changes in Gastric Volume and Their Implications for Weight Loss after Laparoscopic Sleeve Gastrectomy
Manuel Ferrer-Marquez et al.
OBESITY SURGERY (2017)
In vitro biphasic dissolution tests and their suitability for establishing in vitro-in vivo correlations: A historical review
Aude Pestieau et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Nonsteroidal anti-inflammatory drugs for postoperative pain control after lumbar spine surgery: A meta-analysis of randomized controlled trials
Zhifeng Zhang et al.
JOURNAL OF CLINICAL ANESTHESIA (2017)
Dual Level Statistical Investigation of Equilibrium Solubility in Simulated Fasted and Fed Intestinal Fluid
Bayan E. Ainousah et al.
MOLECULAR PHARMACEUTICS (2017)
Magnetic Resonance Imaging Quantification of Fasted State Colonic Liquid Pockets in Healthy Humans
Kathryn Murray et al.
MOLECULAR PHARMACEUTICS (2017)
Weight and Metabolic Outcomes 12 Years after Gastric Bypass
Ted D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management
Luca Busetto et al.
OBESITY FACTS (2017)
Instrumentation of Flow-Through USP IV Dissolution Apparatus to Assess Poorly Soluble Basic Drug Products: a Technical Note
Alice Paprskarova et al.
AAPS PHARMSCITECH (2016)
Higher plasma motilin levels in obese patients decrease after Roux-en-Y gastric bypass surgery and regulate hunger
E. Deloose et al.
GUT (2016)
Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations
Tian Xie et al.
PHARMACEUTICAL RESEARCH (2016)
Risk Factors for Marginal Ulcer After Gastric Bypass Surgery for Obesity: A Population-based Cohort Study
Emma Sverden et al.
ANNALS OF SURGERY (2016)
Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations
Carmil Azran et al.
OBESITY REVIEWS (2016)
NSAID Use after Bariatric Surgery: a Randomized Controlled Intervention Study
Jan Peter Yska et al.
OBESITY SURGERY (2016)
Association Between Overweight and Obesity and Risk of Clinically Diagnosed Knee, Hip, and Hand Osteoarthritis
Carlen Reyes et al.
ARTHRITIS & RHEUMATOLOGY (2016)
The mechanism for increasing the oral bioavailability of poorly water-soluble drugs using uniform mesoporous carbon spheres as a carrier
Tianyi Wang et al.
DRUG DELIVERY (2016)
Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib
Tore K. Kvien et al.
BMC MUSCULOSKELETAL DISORDERS (2015)
Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations
Ina Gesquiere et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
The use of captisol (SBE7-β-CD) in oral solubility-enabling formulations: Comparison to HPβCD and the solubility-permeability interplay
Avital Beig et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Application of Absorption Modeling to Predict Bioequivalence Outcome of Two Batches of Etoricoxib Tablets
Amitava Mitra et al.
AAPS PHARMSCITECH (2015)
Quantification of Gastrointestinal Liquid Volumes and Distribution Following a 240 mL Dose of Water in the Fasted State
Deanna M. Mudie et al.
MOLECULAR PHARMACEUTICS (2014)
Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo Observations
Khaled Abduljalil et al.
DRUG METABOLISM AND DISPOSITION (2014)
The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-off
Avital Beig et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Evaluation of an In Silico PBPK Post-Bariatric Surgery Model through Simulating Oral Drug Bioavailability of Atorvastatin and Cyclosporine
A. S. Darwich et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Celecoxib pathways: pharmacokinetics and pharmacodynamics
Li Gong et al.
PHARMACOGENETICS AND GENOMICS (2012)
Practical use of the regression offset approach for the prediction of in vivo intrinsic clearance from hepatocytes
Anna-Karin Sohlenius-Sternbeck et al.
XENOBIOTICA (2012)
Chemical and in vitro enzymatic stability of newly synthesized celecoxib lipophilic and hydrophilic amides
Amjad M. Qandil et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling
Yasushi Shono et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Computer simulations using GastroPlus™ to justify a biowaiver for etoricoxib solid oral drug products
Arthur Okumu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Toward an Increased Understanding of the Barriers to Colonic Drug Absorption in Humans: Implications for Early Controlled Release Candidate Assessment
Christer Tannergren et al.
MOLECULAR PHARMACEUTICS (2009)
Clinical use and pharmacological properties of selective COX-2 inhibitors
Shaojun Shi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Predictors of endoscopic findings after Roux-en-Y gastric bypass
Jason A. Wilson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
In vitro dissolution studies of sodium diclofenac granules coated with Eudragit L-30D-55® by fluidized-bed system
O. S. Silva et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2006)
Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
Trudy Rodgers et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging
C Schiller et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
The high solubility definition of the current FDA Guidance on Biopharmaceutical Classification System may be too strict for acidic drugs
M Yazdanian et al.
PHARMACEUTICAL RESEARCH (2004)
The effects of modifying in vivo cytochrome P450 3A (CYP3A) activity on etoricoxib pharmacokinetics and of etoricoxib administration on CYP3A activity
NGB Agrawal et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Pharmacokinetics of etoricoxib in patients with hepatic impairment
NGB Agrawal et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man
NGB Agrawal et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Absorption, metabolism, and excretion of etoricoxib, a potent and selective cyclooxygenase-2 inhibitor, in healthy male volunteers
AD Rodrigues et al.
DRUG METABOLISM AND DISPOSITION (2003)
In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663)
N Chauret et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Clinical pharmacokinetics and pharmacodynamics of celecoxib - A selective cyclo-oxygenase-2 inhibitor
NM Davies et al.
CLINICAL PHARMACOKINETICS (2000)